Modeling tuberculosis pathogenesis through ex vivo lung tissue infection

Accepted Manuscript Modeling tuberculosis pathogenesis through ex vivo lung tissue infection Pilar Carranza-Rosales, Irma Edith Carranza-Torres, Nancy Elena Guzmán-Delgado, Gerardo Lozano-Garza, Licet Villarreal-Treviño, Carmen Molina-Torres, Javier Vargas Villarreal, Lucio Vera-Cabrera, Jorge Castro-Garza PII:

S1472-9792(17)30132-4

DOI:

10.1016/j.tube.2017.09.002

Reference:

YTUBE 1622

To appear in:

Tuberculosis

Received Date: 3 April 2017 Revised Date:

6 September 2017

Accepted Date: 10 September 2017

Please cite this article as: Carranza-Rosales P, Carranza-Torres IE, Guzmán-Delgado NE, LozanoGarza G, Villarreal-Treviño L, Molina-Torres C, Villarreal JV, Vera-Cabrera L, Castro-Garza J, Modeling tuberculosis pathogenesis through ex vivo lung tissue infection, Tuberculosis (2017), doi: 10.1016/ j.tube.2017.09.002. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1 1

Modeling tuberculosis pathogenesis through ex vivo lung tissue infection

2

Pilar Carranza-Rosalesa, Irma Edith Carranza-Torresa,b, Nancy Elena Guzmán-Delgadoc,

4

Gerardo Lozano-Garzaa, Licet Villarreal-Treviñob, Carmen Molina-Torresd, Javier Vargas

5

Villarreala, Lucio Vera-Cabrerad, Jorge Castro-Garzaa.

RI PT

3

6 7

a

8

Abril 501 ote, Col. Independencia, Monterrey, N.L. 64720, Monterrey, N.L. México.

9

[email protected], [email protected], [email protected],

SC

Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, 2 de

[email protected]

11

b

12

Nuevo León. Avenida Pedro de Alba y Manuel L. Barragán s/n, Cd. Universitaria, 66450, San

13

Nicolás de los Garza, N.L., México. [email protected]

15 16

Departamento de Microbiología, Facultad de Ciencias Biológicas. Universidad Autónoma de

c

Departamento de Patología, Unidad Médica de Alta Especialidad # 34, Instituto Mexicano del

Seguro Social, Monterrey, N.L., 64730, México. [email protected] d

Servicio de Dermatología, Hospital Universitario “José E. González”, Universidad Autónoma de

TE D

14

M AN U

10

17

Nuevo León, Madero y Gonzalitos, Col. Mitras Centro, Monterrey, N.L. México.

18

[email protected], [email protected]

19

22 23 24 25 26 27 28 29 30 31

Jorge Castro-Garza

EP

21

* Corresponding author:

Centro de Investigación Biomédica del Noreste Instituto Mexicano del Seguro Social 2 de Abril 501 ote, Col. Independencia

AC C

20

Monterrey, N.L. 64720 México Tel: +52-81-8190-4036 FAX: +52-81-8190-4035 e-mail: [email protected]

ACCEPTED MANUSCRIPT 2

ABSTRACT.

33

Tuberculosis (TB) is one of the top 10 causes of death worldwide. Several in vitro and in vivo

34

experimental models have been used to study TB pathogenesis and induction of immune

35

response during Mycobacterium tuberculosis infection. Precision cut lung tissue slices

36

(PCLTS) is an experimental model, in which all the usual cell types of the organ are found,

37

the tissue architecture and the interactions amongst the different cells are maintained. PCLTS

38

in good physiological conditions, monitored by MTT assay and histology, were infected with

39

either virulent Mycobacterium tuberculosis strain H37Rv or the TB vaccine strain

40

Mycobacterium bovis BCG. Histological analysis showed that bacilli infecting lung tissue

41

slices were observed in the alveolar septa, alveolar light spaces, near to type II pneumocytes,

42

and inside macrophages. Mycobacterial infection of PCLTS induced TNF-α production, which

43

is consistent with previous M. tuberculosis in vitro and in vivo studies. This is the first report of

44

using PCLTS as a system to study M. tuberculosis infection. The PCLTS model provides a

45

useful tool to evaluate the innate immune responses and other aspects during the early

46

stages of mycobacterial infection.

50 51 52 53 54 55 56 57

EP

49

Key Words: Mycobacterium tuberculosis; Lung; Tissue slices; Pathogenesis.

AC C

48

TE D

47

M AN U

SC

RI PT

32

ACCEPTED MANUSCRIPT 3

1. INTRODUCTION.

59

Mycobacterium tuberculosis, the primary cause of human tuberculosis (TB), has infected one

60

third of all humanity, and it is a leading cause of death by a single infectious agent [1].

61

Diverse approaches have been used to study TB pathogenesis. Discovery of mechanisms of

62

adherence, infection routes, secreted or contact-dependent bacterial factors, evasion of

63

immune response, signaling, and dissemination in tissues have been possible using in vitro

64

and in vivo models. Such studies can reveal useful information to aid in the development of

65

products or strategies to prevent or treat TB. Both, in vitro as well as in vivo experimental

66

systems have advantages and limitations. Each has become complementary to the other to

67

dissect the pathogenic mechanisms of microorganisms and host immune response.

68

An alternative model, bridging in vivo and in vitro, is an ex vivo model that uses original tissue

69

explants: the precision cut lung tissue slices (PCLTS). In this system, all of the typical cell

70

types of the organ are found, the tissue architecture and interactions between the different

71

cells are maintained, and metabolic and transport functions are preserved [2].

72

Lung tissue slices have been used for toxicity studies [3], biotransformation [4], metabolism of

73

xenobiotics [5], and to study infectious agents like coronavirus [6], retrovirus [7], influenza and

74

parainfluenza viral strains [2,8-12], viruses of the bovine respiratory disease complex [13-14],

75

respiratory syncytial virus (RSV), and only one bacteria Chlamydophila pneumonia [15].

76

These reports show that lung tissue slices can be used in modeling different aspects of

77

infection processes by various pathogens.

78

In the current study, we have optimized PCLTS for use as an alternative model to study

79

mycobacterial infection in lung tissue.

81 82 83

SC

M AN U

TE D

EP

AC C

80

RI PT

58

2. MATERIAL AND METHODS.

2.1 Bacterial strains and growth conditions

84 85

M. tuberculosis strain H37Rv and M. bovis BCG were cultured in Middlebrook 7H9 broth

86

supplemented with oleic acid/albumin/dextrose/catalase (OADC), grown to mid-logarithmic

ACCEPTED MANUSCRIPT 4

phase, and stored at -70 °C until needed. Bacterial titers for each batch of frozen stocks were

88

determined in triplicate by colony-forming units (CFU) counting on Middlebrook 7H10 agar.

89

Before infection experiments, aliquots of bacterial stocks were thawed at 37°C, mixed

90

vigorously by vortexing, and diluted in tissue-culture medium to provide inocula to achieve the

91

Multiplicity of Infection (MOI) indicated. MOI was confirmed from these preparations by CFU

92

counting on Middlebrook 7H10 agar for each experiment.

93 94

2.2 Precision cut lung tissue slices preparation

SC

95

RI PT

87

PCLTS were prepared from 18-20 weeks old male BALB/c mice (Mus musculus) (Harlan

97

Mexico). Mice were euthanized by cervical dislocation following institutional and international

98

guidelines for humanitarian care of animals used in experimental work. Then pleural cavity

99

was exposed under aseptic conditions and trachea was cannulated to infiltrate the lungs with

100

0.7% low-gelling temperature agarose in RPMI 1640 medium at 37°C. Tissues were allowed

101

to cool with ice to obtain an appropriately-firm consistency to cut the slices and the lungs were

102

excised and immersed in sterile Krebs-Henseleit (KB) buffer (pH 7.4 at 4°C).

103

Five millimeter diameter cores of lung tissue were obtained and then the cores were cut with

104

a Brendel Vitron tissue slicer (Vitron, Tucson, AZ, USA) in oxygenated KB buffer (4 °C, 95:5%

105

O2:CO2) into 350-400 µm thick tissue slices.

106

PCLTS were transferred into 24-well microplates (one per well) with 1 ml of DMEM/F12

107

medium supplemented with 10% bovine fetal serum and 25 mM glucose. PCLTS were

108

incubated at 37°C and 5% CO 2 in an orbital shaker (~40 rpm). After 1 h, medium was

109

changed every 30 min to remove agarose.

110

Viability of PCLTS was determined by tetrazolium dye MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-

111

Diphenyltetrazolium Bromide) assay in 24 well plates [16]. OD570nm values were read in a

112

microplate reader (Synergy HT, Biotek, Winooski, VT, USA). Viability of PCLTS was 95 % at

113

72 h was (data not shown).

115

TE D

EP

AC C

114

M AN U

96

2.3 Infection of PCLTS

116 117

Immediately after the last wash to remove agarose, the PCLTS were infected with 1.8 X 106

118

bacterial inoculum in 300 µl applied on top of the slices. Infected lung slices were incubated

ACCEPTED MANUSCRIPT 5 119

stationary for 1 h to facilitate adherence and infection. Then, 700 µl of complete DMEM/F12

120

medium was added to each well and the microplates were incubated at 37°C and 5% CO2 in

121

an orbital shaker (~40 rpm) for different infection periods. CFU were determined by plating in

122

triplicate on Middlebrook 7H10 agar at each time point.

124

RI PT

123

2.4 Histopathological analysis

125

After the indicated infection times, PCLTS were fixed with buffered formalin (10% in PBS) at

127

4°C for 24 h to inactivate the mycobacteria [17]. A different microplate was used for each time

128

point to avoid formaldehyde vapors from affecting other slice cultures. Infected and control

129

slices were embedded in paraffin using an automated tissue processor (Citadel 1000,

130

Shandon, Pennsylvania, USA). Sections of 5 µm thickness were obtained from the embedded

131

tissues using a microtome (Vitron Inc, Tucson, AZ). The sections were stained with

132

hematoxylin & eosin (H&E) or Ziehl-Neelsen (Z-N) dyes and visualized under a conventional

133

light microscope.

134 135

2.5 RNA Extraction and cDNA synthesis

TE D

136

M AN U

SC

126

At each time point, uninfected and infected PCLTS were transferred into RNAlater® solution,

138

kept at 4°C for 12 h, and then stored at -20°C. RNA was extracted from all the samples at the

139

same time using the RNeasy® Protect Mini kit (Qiagen) following manufacturer instructions.

140

Quantity and purity of RNA were determined using a NanoDrop Spectrophotometer ND-1000

141

(Thermo Scientific, Massachusetts, USA). Integrity of RNA was visualized in agarose gels

142

(1.5%) under denaturing conditions. Reverse transcription was performed using the ImProm-II

143

Reverse Transcription System from Promega® (Madison, Wisconsin, USA) with random

144

hexamers following manufacturer instructions. The generated cDNA was stored at -20°C until

145

used.

147

AC C

146

EP

137

2.6 Analysis of TNF-α expression

148 149

Quantitative PCR assays for TNF-α were carried on by using TaqMan® Gene Expression

150

Assays labeled with FAM™ (Dye/MGB Probe) from Applied Biosystems. As endogenous

ACCEPTED MANUSCRIPT 6

gene expression control, the murine GAPDH gene labeled with VIC (Dye/MGB Probe) was

152

used. Each reaction mix contained 12.5 µl of TaqMan® Universal PCR Master Mix (2X), 1.25

153

µl of TaqMan® Gene Expression Assay (20X) Mix, 3 µl of cDNA (100 ng/µl) and 11.7 µl of

154

nuclease-free water for a final volume of 25 µl. PCR was run in a 7500 Real Time PCR

155

System from Applied Biosystems using the following parameters: (1) 50°C for 2 min, (2) 95°C

156

for 10 min, and (3) 95°C for 15 sec, then 60°C for 1 min; step 3 was repeated 40 times. Cycle

157

threshold (CT) data were exported to Excel to calculate expression levels comparing infected

158

vs infected tissue lung slices at the same time point by ∆∆CT method using the following

159

equation:

SC

RI PT

151

160

∆∆CT, = (mean CT, TNFα gene, infected – mean CT, GAPDH gene, infected) – (mean CT, TNFα gene, uninfected –

162

mean CT, GAPDH gene, uninfected)

M AN U

161

163

2- ∆∆CT = Expression of target gene in infected lung slices compared to the expression of

165

target gene in uninfected lung slices for each time point.

166

Then, an ANOVA analysis using the Dunnett’s method (p< 0.05) for comparison of means

167

was performed to determine significance of values at the different time points.

168

TE D

164

3. RESULTS

170

3.1 Histopathological analysis

171

Histopathological analysis of BALB/c mouse PCLTS by H & E staining showed that uninfected

172

lung tissue slices maintained normal tissue architecture with no evidence of tissue damage up

173

to 5 days of culture (Figure 1). In infected PCLTS, at 24 h after infection, there was an

174

increase in lymphocytes in areas where bacilli were located (Figure 2). Mycobacteria infected

175

PCLTS showed a mild inflammatory response characterized by the presence of lymphocytes,

176

macrophages and multinucleated cells.

177

Figures 3 show PCLTS sections infected with M. tuberculosis H37Rv or M. bovis BCG at

178

different time points (0-48 h). M. bovis BCG bacilli were mainly located as free bacilli in the

AC C

EP

169

ACCEPTED MANUSCRIPT 7

alveolar spaces and sometimes near type II pneumocytes. M. tuberculosis bacilli were located

180

nearer to alveolar septa and near or in contact with type II pneumocytes.

181

Mycobacteria-infected PCLTS showed bacilli in the alveolar spaces with a tendency to group

182

in the alveolar septum, near to or in contact with epithelial cells, but no bacteria were seen

183

within pneumocytes. Meanwhile, intracellular bacteria were observed inside macrophages

184

(Figure 4). Presence of multinucleated giant cells and inflammatory cell aggregates,

185

characteristic of a granulomatous disease like tuberculosis, were also frequently seen (Figure

186

4).

187

3.2. Mycobacteria CFU in PCLTS

188

Table 1 shows the CFU of both M. tuberculosis H37Rv and M. bovis BCG in PLCTS at

189

different time points. There were not statically differences in number of CFU per slice.

190

3.3. TNF-α expression in infected lung slices

191

Comparison of TNF-α induction by mycobacteria infection by the ∆∆Ct method indicated that

192

TNF-α expression was higher in lung tissue slices infected with M. bovis BCG than in infected

193

lung slices infected with M. tuberculosis. The peak of expression was at 6 h with M.

194

tuberculosis producing an increase of 2.62 fold and M. bovis BCG increasing 3.38 fold (Figure

195

5). Results of Dunnett’s analysis of TNF-α gene expression are statistically significant for M.

196

bovis BCG at 2, 6, 12 and 24 h and M. tuberculosis at 6 h compared to control values (Figure

197

5).

EP

TE D

M AN U

SC

RI PT

179

198

4. DISCUSSION

200

Despite all of the recent M. tuberculosis studies, there remain many unknown mechanisms

201

associated with the tuberculosis pathogenesis due to the complex interactions between

202

mycobacteria and host cells. Several in vivo and in vitro models have been useful to obtain

203

information on different aspects of tuberculosis disease initiation and progression. Both types

204

of models have advantages and weaknesses and in the end, they have become

205

complementary to each other as sources of valuable data on M. tuberculosis virulence factors

206

as well as on host immune responses to the pathogen. Here, we present an alternative and

AC C

199

ACCEPTED MANUSCRIPT 8

complementary ex vivo model using murine precision cut lung tissue slices to study M.

208

tuberculosis infection. In this system all the usual cell types of the lung are present, the tissue

209

architecture is maintained, as are the interactions between the different cells, and also

210

important, the metabolic and transport functions are preserved. Additionally, at present it is

211

virtually impossible to stop using animals in research and in a support for the moral and

212

ethical issues handling experimental animals, this model reduces the number of animals used

213

by experiment.

214

The main target organ for M. tuberculosis infection is the lung; therefore, respiratory tissue is

215

the obvious first choice to evaluate PCLTS to study M. tuberculosis interactions with lung

216

cells. Harford and Hamlin [18], prepared murine tissue slices by hand and reported the lung

217

slices as an infection model for influenza virus, confirming the good physiological condition of

218

the tissue by the presence of active ciliary movement. The first report on precision cut lung

219

slices was a study published by Ebsen et al. [15], in which lung slices were infected with

220

Chlamydophila pneumoniae and respiratory syncytial virus. By using morphological analyses,

221

these authors demonstrated that bacterial and viral infections can be successfully performed

222

in this system.

223

Researchers have also infected PCLTS with different viruses (retrovirus, influenza virus and

224

parainfluenza virus). In all reported PCLTS studies, the model showed reproducibility and the

225

PCLTS had good physiological conditions during the time of the assay [7, 12, 15]. Recently,

226

PCLTS from sheep were infected with Jaagsiekte sheep retrovirus, the causative agent of

227

ovine pulmonary adenocarcinoma. The virus was able to infect cells, produce new infectious

228

virions, and induce cell proliferation. Also, infected lung slice cells expressed markers of type

229

II pneumocytes and phosphorylated Akt and ERK1/2, resembling the phenotype of natural

230

and experimentally-derived OPA in sheep [7].

231

A critical factor on PCLTS model is how the tissue is maintained in good physiological

232

conditions to perform the experiments. Previous work in our lab showed that murine PCLTS

233

are viable up to 96 h after obtaining, as monitored by MTT assay and histological studies [19];

234

all the experiments in this study were done during the first 24 h after infection assuring that

235

PCLTS were suitable to work. Umachandran and colleagues [20], showed that in their

236

conditions rat PCLTS were metabolically viable for 8 h, a short time compared with our

237

murine PCLTS; however, differences may be due to how the tissues were obtained and

AC C

EP

TE D

M AN U

SC

RI PT

207

ACCEPTED MANUSCRIPT 9

incubated. Moreover, the rat slice thickness mean was 600 nm, which may limit gas exchange

239

and adequate nutrient flow into the tissue compared to the 450 µm thickness of our slices.

240

One of the main goals in this work was the optimization to obtain, culture and establish

241

reproducible M. tuberculosis infections. Previously, Arriaga et al, [21] detected presence of

242

mycobacterial DNA by PCR in situ in macrophages, fibroblasts, endothelial and bronchial

243

epithelial cells of experimental infected mice after 30 days post-infection, indicating these

244

cells can be infected by M. tuberculosis. In the PCLTS we observed bacilli in contact with

245

epithelial cells as well as intracellular bacteria in macrophages. Bacteria were easily located

246

in alveolar space and close or in contact with type II pneumocytes. Although we did not find

247

evidence of intracellular bacteria in these cells, it cannot be discarded cell invasion occurs.

248

Our model analyze early stages of infection up to 48 h and further ultrastructure analysis is

249

needed to confirm infection of pneumocytes in PCLTS. Detailed comparisons of

250

mycobacterial infections in PCLTS to infections by other species may reveal common

251

mechanisms to human infection. The close proximity of mycobacteria to pneumocytes type II

252

in PCLTS may represent a relevant and preferential location to the infection process as it is

253

well known that mycobacteria invade human lung epithelial cells [22-26].

254

The histological analysis showed, 24 h after M. tuberculosis infection, a moderate infiltrate of

255

immune cells into the areas with a higher number of M. tuberculosis bacteria. This movement

256

is similar to the increase of lymphocytes and plasmacytic cells in infection areas with

257

respiratory syncytial virus (RSV) and Chlamydophila pneumoniae observed by Ebsen et al.

258

[15] in mice PCLTS. Migration of immune cells is a signal that PCLTS remain

259

immunologically active. Henjakovic et al. [27] reported that immunoactive substances such as

260

lipopolysaccharide (LPS), macrophage-activating lipopeptide-2 (MALP-2), interferon-γ (IFNγ),

261

and dexamethasone induced the characteristic responses to these substances in PCLTS.

262

These facts support this model as suitable to test immune responses against pathogens.

263

Further studies on the phenotype of the immune cells in PCLTS will determine what kind of

264

cells interact directly with Mycobacterium. One advantage of this system is the possibility to

265

add exogenous specific immune cell types to the PCLTS and analyze the role of each cell

266

linage during the challenge with microbes.

267

Therefore, to analyze the ability of PCLTS to respond immunologically we tested the TNF-α

268

induction on PCLTS infected with mycobacteria. M. bovis BCG induced a higher amount of

AC C

EP

TE D

M AN U

SC

RI PT

238

ACCEPTED MANUSCRIPT 10

TNF-α than M. tuberculosis H37Rv, measured by qRT-PCR. Peaks of expression were at 6 h

270

after infection with an increase of 2.62 and 3.38 fold for M. tuberculosis and M. bovis BCG,

271

respectively. Differences in expression are not due to differential growth of strains as

272

differences in the number of CFU per slice were not statistically significant as shown in table

273

1, but due to differential TNF-α induction by the infecting strains. These results agree with

274

those reported by Wong et al. [28] where they found that virulent strains produced a lower

275

induction of TNF-α than non-virulent strains. These findings suggest that virulent strains may

276

inhibit cellular mechanism to evade innate immune response. An example is the suppression

277

of IL-12 production and negative regulation of apoptosis in host macrophages [29-31] which

278

would allow mycobacteria to survive inside the cells protected from immune response, helping

279

further tissue dissemination.

280

In a report of ex vivo human lung tissue infected with M. tuberculosis, M. avium and M.

281

abscessus, Ganbat et al. [32], found macrophages, neutrophils, monocytes, and

282

pneumocytes-II infected with mycobacteria and nuclear alterations resulting in cell death

283

depending on the mycobacterial species used. This system provides a similarity to the original

284

lung microenvironment with its native cell population, orientation, and structural integrity. In

285

comparison, our model provide homogenous tissue size, favoring gas exchange, nutrient

286

availability, and allowing viability of tissue up to 96 h. Also, mycobacterial inoculum used in

287

our experiments is lower and distribution of bacteria is easier due to the size of the PCLTS.

288

Morphological changes and the induction of TNF-α of PCLTS experimentally infected with

289

mycobacteria suggest this system as an alternative model to study different aspects of

290

tuberculosis pathogenesis under controlled conditions in a closest way to what occurs in vivo.

291

Also, the number of animals used by this approach is lower than typical in vivo models. The

292

possible use of PCLTS to study immune responses, virulence factor action, or even to test

293

therapeutic agents are some facets to explore in future research.

295 296 297

SC

M AN U

TE D

EP

AC C

294

RI PT

269

ACCEPTED MANUSCRIPT 11

ACKNOWLEDGEMENT

299

We would like to thank Russell K. Karls for the critical review of the manuscript.

300

This work was supported by PAICYT-UANL CN 1534-07, FIS-IMSS 2005/1/I/070

301

FIS/IMSS/PROT/008, INMUNOCANEI-CONACYT 253053. The funders had no role in study

302

design, data collection and analysis, decision to publish, or preparation of the manuscript.

RI PT

298

303

SC

304 305

M AN U

306 307 308

312 313 314 315 316 317 318 319 320

EP

311

AC C

310

TE D

309

ACCEPTED MANUSCRIPT 12 321 322 323

REFERENCES 1. World Health Organization. Tuberculosis fact sheet, http://www.who.int/mediacentre/factsheets/fs104/en/; 2016 [accessed 16.12.20]. 2. Liu R, An L, Liu G, Li X, Tang W, Chen X. Mouse lung slices: an ex vivo model for the

325

evaluation of antiviral and anti-inflammatory agents against influenza viruses. Antiviral

326

Res. 2015; 120: 101-11. DOI: http://dx.doi.org/10.1016/j.antiviral.2015.05.008.

327

RI PT

324

3. Fisher RL, Smith MS, Hasal SJ, Hasal KS, Gandolfi AJ, Brendel K. The use of human lung slices in toxicology. Hum Exp Toxicol. 1994; 13: 466-71. DOI:

329

http://dx.doi.org/10.1177/096032719401300703.

SC

328

4. Wohlsen A, Marti C, Vollmer E, Branscheid D, Magnussen H, Becker WM, Lepp U, Uhlig

331

S. The early allergic response in small airways of human precision-cut lung slices. Eur

332

Respir J. 2003; 21: 1024-32. DOI: http://dx.doi.org/10.1183/09031936.03.00027502.

333

5. de Kanter R, Monshouwer M, Meijer DK, Groothuis GM. Precision-cut organ slices as a

M AN U

330

334

tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic

335

tissues. Curr Drug Metab. 2002; 3: 39-59. DOI:

336

http://dx.doi.org/10.2174/1389200023338071.

6. Abd El Rahman S, Winter C, El-Kenawy A, Neumann U, Herrler G. Differential sensitivity

338

of well-differentiated avian respiratory epithelial cells to infection by different strains of

339

infectious bronchitis virus. J Virol. 2010; 84: 8949-52. DOI:

340

http://dx.doi.org/10.1128/JVI.00463-10.

7. Cousens C, Alleaume C, Bijsmans E, Martineau HM, Finlayson J, Dagleish MP, Griffiths

EP

341

TE D

337

DJ. Jaagsiekte sheep retrovirus infection of lung slice cultures. Retrovirology. 2015; 12:

343

31.

344

DOI: http://dx.doi.org/10.1186/s12977-015-0157-5.

345

AC C

342

8. Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, Mossman KL, Taylor JD,

346

Stämpfli MR. Treating viral exacerbations of chronic obstructive pulmonary disease:

347

insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One.

348

2010; 5: e13251. DOI: http://dx.doi.org/10.1371/journal.pone.0013251.

349

9. Meng F, Punyadarsaniya D, Uhlenbruck S, Hennig-Pauka I, Schwegmann-Wessels C,

350

Ren X, Dürrwald R, Herrler G. Replication characteristics of swine influenza viruses in

351

precision-cut lung slices reflect the virulence properties of the viruses. Vet Res. 2013; 44:

352

110.

ACCEPTED MANUSCRIPT 13 353 354

DOI: http://dx.doi.org/10.1186/1297-9716-44-110. 10. Dobrescu I, Levast B, Lai K, Delgado-Ortega M, Walker S, Banman S, Townsend H, Simon G, Zhou Y, Gerdts V, Meurens F. In vitro and ex vivo analyses of co-infections with

356

swine influenza and porcine reproductive and respiratory syndrome viruses. Vet

357

Microbiol. 2014; 169: 18-32. DOI: http://dx.doi.org/10.1016/j.vetmic.2013.11.037.

358

RI PT

355

11. Punyadarsaniya D, Liang CH, Winter C, Petersen H, Rautenschlein S, Hennig-Pauka I, Schwegmann-Wessels C, Wu CY, Wong CH, Herrler G. Infection of differentiated porcine

360

airway epithelial cells by influenza virus: differential susceptibility to infection by porcine

361

and avian viruses. PLoS One. 2011; 6(12):e28429. DOI:

362

http://dx.doi.org/10.1371/journal.pone.0028429.

363

SC

359

12. Delgado-Ortega M, Melo S, Punyadarsaniya D, Ramé C, Olivier M, Soubieux D, Marc D, Simon G, Herrler G, Berri M, Dupont J, Meurens F. Innate immune response to a H3N2

365

subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages,

366

and precision-cut lung slices. Vet Res. 2014; 45: 42. DOI: http://dx.doi.org/10.1186/1297-

367

9716-45-42.

368

M AN U

364

13. Kirchhoff J, Uhlenbruck S, Goris K, Keil GM, Herrler G. Three viruses of the bovine respiratory disease complex apply different strategies to initiate infection. Vet Res. 2014;

370

45: 20. DOI: http://dx.doi.org/10.1186/1297-9716-45-20.

TE D

369

14. Kirchhoff J, Uhlenbruck S, Keil GM, Schwegmann-Wessels C, Ganter M, Herrler G.

372

Infection of differentiated airway epithelial cells from caprine lungs by viruses of the

373

bovine respiratory disease complex. Vet Microbiol. 2014; 170: 58-64. DOI:

374

http://dx.doi.org/10.1016/j.vetmic.2014.01.038.

EP

371

15. Ebsen M, Mogilevski G, Anhenn O, Maiworm V, Theegarten D, Scharze J, Morgenroth K.

376

Infection of murine precision cut lung slices (PCLS) with respiratory syncytial virus (RSV)

377

and Chalmydophila pneumoniae using the Krumdieck technique. Pathol Res Pract. 2002;

378

198: 747-53. DOI: http://dx.doi.org/10.1078/0344-0338-00331.

379

AC C

375

16. Dassow C, Wiechert L, Martin C, Schumann S, Müller-Newen G, Pack O, Guttmann J,

380

Wall WA, Uhlig S. Biaxial distension of precision-cut lung slices. J Appl Physiol. 2010;

381

108:713-21. DOI: http://dx.doi.org/10.1152/japplphysiol.00229.2009.

382

17. Castro-Garza J, Barrios-García HB, Cruz-Vega DE, Said-Fernández S, Carranza-Rosales

383

P, Molina-Torres CA, Vera-Cabrera L. Use of a colorimetric assay to measure differences

384

in cytotoxicity of Mycobacterium tuberculosis strains. J Med Microbiol. 2007; 56: 733-7.

ACCEPTED MANUSCRIPT 14 385 386

DOI: http://dx.doi.org/10.1099/jmm.0.46915-0. 18. Harford CG and Hamlin A. Effect of influenza virus on cilia and epithelial cells in the

387

bronchi of mice. J Exp Med. 1952; 95: 173-90. DOI:

388

http://dx.doi.org/10.1084/jem.95.2.173. 19. Jaramillo-Reyna E. 2006. Rebanadas de tejidos: un modelo alternativo en investigación

RI PT

389 390

biomédica (Undergraduate Thesis). Universidad Autónoma de Nuevo León. Nuevo León,

391

México.

392

20. Umachandran M, Howarth J, Ioannides C. Metabolic and structural viability of precisioncut rat lung slices in culture. Xenobiotica. 2004; 34: 771-80. DOI:

394

http://dx.doi.org/10.1080/00498250400000816.

395

SC

393

21. Arriaga AK, Orozco EH, Aguilar LD, Rook GA, Hernández Pando R. Immunological and pathological comparative analysis between experimental latent tuberculous infection and

397

progressive pulmonary tuberculosis. Clinical and Experimental Immunology. 2002; 128:

398

229-37. http://dx.doi.org/10.1046/j.1365-2249.2002.01832.x

M AN U

396

22. Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook

400

GAW, Bjune G. Persistence of DNA from Mycobacterium tuberculosis in superficially

401

normal lung tissue during latent infection. The Lancet. 2000; 356: 2133-38.

402

http://dx.doi.org/10.1016/S0140-6736(00)03493-0.

403

TE D

399

23. Castro-Garza J, King CH, Swords WE, Quinn FD. Demonstration of spread by

404

Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers. FEMS Microbiol

405

Lett. 2002; 212: 145-9. DOI: http://dx.doi.org/10.1111/j.1574-6968.2002.tb11258.x. 24. García-Pérez BE, Mondragón-Flores R, Luna-Herrera J. Internalization of Mycobacterium

407

tuberculosis by macropinocytosis in non-phagocytic cells. Microb Pathog. 2003; 35: 49-

408

55.

409

DOI: http://dx.doi.org/10.1016/S0882-4010(03)00089-5.

AC C

410

EP

406

25. García-Pérez BE, Hernández-González JC, García-Nieto S, Luna-Herrera J.

411

Internalization of a non-pathogenic mycobacteria by macropinocytosis in human alveolar

412

epithelial A549 cells. Microb Pathog. 2008; 45: 1-6. DOI:

413

http://dx.doi.org/10.1016/j.micpath.2008.01.009.

414

26. Rivas-Santiago B, Contreras JC, Sada E, Hernández-Pando R. The potential role of lung

415

epithelial cells and beta-defensins in experimental latent tuberculosis. Scand J Immunol.

416

2008; 67: 448-52. DOI: http://dx.doi.org/10.1111/j.1365-3083.2008.02088.x.

ACCEPTED MANUSCRIPT 15 417

27. Henjakovic M, Sewald K, Switalla S, Kaiser D, Müller M, Veres TZ, Martin C, Uhlig S,

418

Krug N, Braun A. Ex vivo testing of immune responses in precision-cut lung slices.

419

Toxicol Appl Pharmacol. 2008; 231: 68-76. DOI:

420

http://dx.doi.org/10.1016/j.taap.2008.04.003. 28. Wong KC, Leong WM, Law HK, Ip KF, Lam JT, Yuen KY, Ho PL, Tse WS, Weng XH,

RI PT

421

Zhang WH, Chen S, Yam WC. Molecular characterization of clinical isolates of

423

Mycobacterium tuberculosis and their association with phenotypic virulence in human

424

macrophages. Clin Vaccine Immunol. 2007; 14: 1279-84. DOI:

425

http://dx.doi.org/10.1128/CVI.00190-07.

426

SC

422

29. Nigou J, Gilleron M, Rojas M, Garcia LF, Thurnher M, Puzo G. Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response.

428

Microbes and Infection. 2002; 4: 945-53. DOI: http://dx.doi.org/10.1016/S1286-

429

4579(02)01621-0.

430

M AN U

427

30. Deretic V, Singh S, Master S, Harris J, Roberts E, Kyei G, Davis A, de Haro S, Naylor J,

431

Lee H, Vergne I. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and

432

autophagy as a host defense mechanism. Cell Microbiol. 2006; 8: 719-27. DOI:

433

http://dx.doi.org/10.1111/j.1462-5822.2006.00705.x.

31. Loeuillet C, Martinon F, Perez C, Munoz M, Thome M, Meylan PR. Mycobacterium

TE D

434 435

tuberculosis subverts innate immunity to evade specific effectors. J Immunol. 2006; 77:

436

6245-55. DOI: http://dx.doi.org/10.4049/jimmunol.177.9.6245.

437

32. Ganbat D, Seehase S, Richter E, Vollmer E, Reiling N, Fellenberg K, Gaede KI, Kugler C, Goldmann T. Mycobacteria infect different cell types in the human lung and cause

439

species dependent cellular changes in infected cells. BMC Pulm Med. 2016; 16: 19. DOI:

440

http://dx.doi.org/10.1186/s12890-016-0185-5.

442 443 444 445

AC C

441

EP

438

ACCEPTED MANUSCRIPT 16

LEGENDS

447

Table 1. Mycobacterial CFU in PLCTS. Differences in number of CFU per slice were not

448

statistically significant. Data represent the average of mycobacteria per slice ± standard

449

deviation. Experiments were performed in triplicate.

RI PT

446

450

Figure 1. Histological analysis of murine precision cut lung tissue slices (PCLTS) by H

452

& E staining. At day 5 of culture, PCLTS show typical and well-preserved lung tissue

453

structure; alveolar space are delimited by fine alveolar septa (1A, 100X magnification),

454

pneumocytes type I (asterisks) are observed as squamous epithelial cells and pneumocytes

455

type II as cuboidal cells (arrows) at the angles where alveolar septal walls converge (1B,

456

400X magnification).

M AN U

SC

451

457

Figure 2. H & E stained PCLTS after 24 h mycobacterial infection. Panels A and B

459

correspond to lung tissue from uninfected PCLTS. Alveolar septa, pneumocytes type I

460

(asterisk) and pneumocytes type II (arrow heads) are evident (panel B). Panels C and D

461

correspond to M. tuberculosis H37Rv-infected PCLTS, while panels E and F to M. bovis BCG-

462

infected PCLTS. In mycobacteria-infected PCLTS, there is an increase of inflammatory

463

response predominantly lymphocytic (circles) (panels D and F). Magnification: 100X (A, C,

464

and E) or 400X (B, D, and F).

EP

465

TE D

458

Figure 3. Acid-fast staining of PCLTS infected with mycobacteria. PCLTS infected with

467

M. tuberculosis H37Rv (A, B, and C) and M. bovis BCG (D, E, and F) at different time points.

468

Multinucleated giant cells (GC), and lymphoplasmacytic infiltrate (asterisks) were evident.

469

Mycobacterial aggregates were seen in the intra-alveolar space (arrows) interacting with

470

macrophages (M), although the bacilli were primarily located near pneumocytes type II and

471

alveolar septa. Staining: H&E (A), Ziehl-Neelsen (B, C, D, E and F). Magnification: 100 X (A

472

and D), and 1000X (B, C, E and F).

473

AC C

466

ACCEPTED MANUSCRIPT 17

Figure 4. Acid-fast staining of PCLTS infected with M. tuberculosis at 24 h post

475

infection. Bacteria (arrows) are in contact with pneumocytes type II (NII) (panel A). Bacilli are

476

also localized near alveolar septa and a macrophage is detected in the lumen of the alveolus

477

(panel B). It was common to find mycobacteria on the surface of the epithelium (panel C) and

478

inside alveolar macrophages (panel D). All sample were Ziehl-Neelsen stained. Magnification:

479

1000X.

RI PT

474

480

Figure 5. TNF-α expression in PCLTS infected with mycobacteria. Bars show levels of

482

relative TNF-α expression. Uninfected PCLTS (purple), M. bovis (green) or M. tuberculosis

483

(blue) infected PCLTS.

M AN U

SC

481

484 485 486

490 491 492 493 494 495 496 497

EP

489

AC C

488

TE D

487

ACCEPTED MANUSCRIPT 18 498 499

Table 1.

502 2h

6h 1.50 ± 0.19 X 10

4

1.64 ± 0.38 X 10

M. tuberculosis H37Rv

1.12 ± 0.19 X 10

M. bovis BCG

1.33 ± 0.27 X 10

4 4

504 505 506

511 512 513 514 515 516 517

EP

510

AC C

509

TE D

507

24 h

4

2.10 ± 0.32 X 10

4

2.30 ± 0.30 X 10

M AN U

503

508

12 h

4

SC

501

RI PT

500

4

2.14 ± 0.19 X 10

4

2.35 ± 0.25 X 10

ACCEPTED MANUSCRIPT 19 518

Figures

519 520

522

RI PT

521

Figure 1

SC

523

M AN U

524

528 529 530 531 532 533 534 535

EP

527

AC C

526

TE D

525

ACCEPTED MANUSCRIPT 20 536 537

Figure 2

539 540 541 542 543

AC C

EP

TE D

M AN U

SC

RI PT

538

ACCEPTED MANUSCRIPT 21 544 545

Figure 3

547 548 549 550 551

AC C

EP

TE D

M AN U

SC

RI PT

546

ACCEPTED MANUSCRIPT 22 552 553

Figure 4

557 558 559 560 561 562 563

EP

556

AC C

555

TE D

M AN U

SC

RI PT

554

ACCEPTED MANUSCRIPT 23 564 565

Figure 5.

Control BCG H37Rv *

4.0

*

*

SC

*

*

3.0

2.0

1.0

0.0 0

2

6

M AN U

TNF-α relative expression

5.0

AC C

EP

TE D

Time (h) 567

RI PT

566

12

24